Biodexa Pharmaceuticals Plc (BDRX)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Feb 27, 16:00
1.07
-0.01
(-0.93%)
After-Hours: 20:00
Biodexa Pharmaceuticals Research and Development Expense (TTM) : 6.352M for June 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NuCana Plc | 15.52M |
| Autolus Therapeutics Plc | 112.77M |
| Mereo BioPharma Group Plc | 22.37M |
| Bicycle Therapeutics Plc | 279.06M |
| DBV Technologies SA | 95.80M |